SCHEMBL19210477

SCHEMBL19210477

CN(Cc1cnccn1)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.44
ABL1 P00519 1/20 0.44
RIN1 Q13671 1/20 0.44
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
HDAC1 Q13547 2/20 0.41
KDM4E B2RXH2 2/20 0.41
NAPRT Q6XQN6 1/20 0.41
HCAR2 Q8TDS4 1/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 1/20 0.40
FNTA P49354 1/20 0.39
FNTB P49356 1/20 0.39
VNN1 O95497 1/20 0.39
HDAC3 O15379 1/20 0.39
HDAC2 Q92769 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10305066 0.83 TDP1 (0.46) TDP1ABL1RIN1RAB9ANPC1
SCHEMBL21655417 0.78 HTR2C (0.41) TDP1ABL1RIN1RAB9ANPC1
SCHEMBL27322956 0.77 BAZ2B (0.43) TDP1ABL1RIN1RAB9ANPC1
SCHEMBL20882979 0.77 GAA (0.45) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL3461681 0.77 CHRNB2 (0.45) TDP1CYP1A2CYP3A4CYP2C9CYP2C19
SCHEMBL6204342 0.75 KDM4E (0.52) TDP1CYP1A2CYP3A4KDM4EKMT2A
SCHEMBL7657928 0.75 SMN1; SMN2 (0.40) TDP1ABL1RIN1RAB9ANPC1
SCHEMBL14067071 0.74 POLB (0.44) TDP1RAB9ANPC1CYP1A2CYP3A4
SCHEMBL19210516 0.74 NPC1 (0.43) RAB9ANPC1LMNAGAA
SCHEMBL10200511 0.74 CA2 (0.45) TDP1ABL1RIN1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2699557-B1 3-(OXAZOL-2-YL-ETHOXY)- AND 3-(THIAZOL-2-YL-ETHOXY)-BENZAMIDE DERIVATIVES AS ANTI-BACTERIAL AGENTS BIOTA SCIENT MANAGEMENT (AU) 2017-08-16 EP claimed
WO-2020023793-A1 PEGYLATED PRODRUGS OF PHENOLIC TRPV1 AGONISTS Concentric Analgesics, Inc. (US) 2020-01-30 WO disclosed